QuidelOrtho Corp (NAS:QDEL)
$ 44.18 2.07 (4.92%) Market Cap: 2.96 Bil Enterprise Value: 5.49 Bil PE Ratio: 0 PB Ratio: 0.89 GF Score: 78/100

Quidelortho Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 08:50PM GMT
Release Date Price: $85.48 (-0.57%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

All right. Thanks, everyone, for joining us. My name is Tejas Savant, and I'm the Life Science Tools And Diagnostics Analyst at Morgan Stanley. It's my pleasure to host Quidel this afternoon. And from the company, we have Doug Bryant, CEO; and Joe Busky, CFO. Thanks for doing this.

Before we get started, a quick disclaimer here for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant;Douglas C. Bryant
Morgan Stanley, Research Division - Equity Analyst;QuidelOrtho Corporation

So with that, Doug, we'll get started. '22 has been quite a transformational year for the Quidel story. Beyond the close of the Ortho transaction, can you highlight some of your key accomplishments year-to-date and just give us a high-level overview of what you're most excited about as we look to '23?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot